Cargando…
Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis
CYP19A1: Aromatase excess syndrome is characterized by pre- or peripubertal onset of gynecomastia due to estrogen excess because of a gain-of-function mutation in the aromatase gene (CYP19A1). Subchromosomal recombination events including duplication, deletion, and inversion has been identified. The...
Autores principales: | Shozu, Makio, Fukami, Maki, Ogata, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK, Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162655/ https://www.ncbi.nlm.nih.gov/pubmed/25264451 http://dx.doi.org/10.1586/17446651.2014.926810 |
Ejemplares similares
-
Molecular Bases and Phenotypic Determinants of Aromatase Excess Syndrome
por: Fukami, Maki, et al.
Publicado: (2012) -
Aromatase excess syndromeas a model for genomic disorder: identification of molecular bases and phenotypic determinants
por: Ogata, Tsutomu, et al.
Publicado: (2013) -
Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021) -
SUN-026 Unusual Presentation of Aromatase Excess Syndrome
por: Al Sabie, Farah Laith, et al.
Publicado: (2020) -
MAMLD1 (CXorf6) is a New Gene for
Hypospadias
por: Ogata, Tsutomu, et al.
Publicado: (2008)